T2 Biosystems (TTOO) Stock Forecast & Price Prediction

Estimation of the future price movement of T2 Biosystems stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target

Current $3.74

Concensus $0.00

Low $0.00

Median $0.00

High $0.00

Based on analysts projections #TTOO is expected to experience a price decline over the next year.

The current average TTOO price target, as estimated by these analysts, is $0.00.

The predictions for the future TTOO stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for TTOO.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

TTOO stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted

There are no data to display

T2 Biosystems (TTOO) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if T2 Biosystems is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.


Financial Scores

Updated on: 29/11/2023

Altman Z-Score: -22.6

Piotroski Score: 2.0

ESG Score

Updated on: 29/11/2023

Environmental: 61.3

Social: 66.3

Governance: 67.8

Financial Health

Updated on: 29/11/2023

DCF: Strong Buy

ROE: Strong Buy

ROA: Strong Sell

Debt to equity ratio: Sell

Price to earnings ratio: Neutral

Price to book ratio: Neutral

TTOO Discounted Cash Flow

Updated on: 29/11/2023

Discounted Cash Flow Value

Current Price

TTOO Revenues by Segment

Updated on: 29/11/2023

Contribution Revenue
Instrument Rentals
Product Consumables
Product Instruments

Revenue from Contract with Customer, Excluding Assessed Tax

TTOO Revenues by Region

Updated on: 29/11/2023


TTOO Notes Due

Updated on: 29/11/2023


There are no data to display

T2 Biosystems (TTOO) Social Sentiments

Monitoring bullish and bearish sentiments towards T2 Biosystems on Twitter and Stocktwits could help to forecast an upward or downward trend in T2 Biosystems stock price.

Promising Stock Forecast for T2 Biosystems in Infectious Disease Diagnostics Market

T2 Biosystems (TTOO) is a leading biotechnology company that operates in the diagnostics and research sector. Founded in 2006, T2 Biosystems has developed revolutionary technologies for rapid and accurate diagnosis of life-threatening infections using cutting-edge biosensors and magnetic resonance technology. T2 Biosystems offers its proprietary T2MR platform that enables clinicians to diagnose sepsis, a potentially fatal infection, within hours instead...
The future looks promising for T2 Biosystems, with positive stock forecasts showing steady growth potential. According to MarketWatch, analysts have a consensus price target of $1.75 for TTOO stock. While this may be lower than its current trading price of $1.94 per share at the time of writing this article, it still represents an increase from its IPO price of $11 per share.

The coronavirus pandemic has put infectious diseases like sepsis at the forefront of public health concerns. With hospitals overwhelmed by COVID-19 patients, rapid and accurate diagnosis of other illnesses becomes even more critical. As a result, there is growing demand for companies like T2 Biosystems who specialize in infectious disease diagnostics.

In conclusion, T2 Biosystems is a leader in the diagnostics and research sector with a strong track record and promising future potential backed by positive stock forecasts. As demand increases for rapid infectious disease diagnosis solutions worldwide amid the COVID-19 pandemic, T2 Biosystems could be positioned for exponential growth.">Read more

Analyzing T2 Biosystems for Stock Prediction in the Diagnostics & Research Sector

The Diagnostics & Research stock market sector has been steadily growing in recent years, with a focus on developing innovative technologies that improve healthcare outcomes. One of the leading companies in this space is T2 Biosystems (stock ticker Diagnostics & Research), which specializes in diagnostic products for detecting and identifying pathogens. T2 Biosystems uses its proprietary magnetic resonance technology to... Read more